Immunotherapy for the Post-Infectious Sequela of SARS-CoV-2 Infection

HTML  XML Download Download as PDF (Size: 223KB)  PP. 117-120  
DOI: 10.4236/wjns.2020.102013    620 Downloads   1,028 Views  


The SARS-CoV-2 2019 pandemic is creating challenges to the management of post-infectious autoimmunity in childhood and adult Covid-19 cases due to its high case fatality. Nearly all of the agents envisioned to treat Covid-19 illness, including the newly recognized pediatric multi-system inflammatory syndrome, impact post-infectious mechanisms in keeping with the multiplier effect of infection, immunity and inflammation, known as I-Cubed (I3).

Share and Cite:

S. Younger, D. (2020) Immunotherapy for the Post-Infectious Sequela of SARS-CoV-2 Infection. World Journal of Neuroscience, 10, 117-120. doi: 10.4236/wjns.2020.102013.

Copyright © 2021 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.